KCNJ10 and juvenile Huntington disease: For instance, gene therapy approaches overexpressing Kir4.1 in astrocytes have shown potential in restoring potassium homeostasis and reducing neuronal hyperexcitability in models of Huntington’s disease, highlighting its applicability for epilepsy [40].